Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 26 | 2023 | 2117 | 2.050 |
Why?
|
| Brain | 24 | 2023 | 1662 | 1.930 |
Why?
|
| Transcriptome | 9 | 2023 | 87 | 1.720 |
Why?
|
| Proteomics | 6 | 2022 | 91 | 1.140 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 140 | 1.110 |
Why?
|
| Algorithms | 4 | 2023 | 370 | 1.070 |
Why?
|
| Cognitive Dysfunction | 12 | 2022 | 1064 | 1.000 |
Why?
|
| Gene Regulatory Networks | 5 | 2020 | 29 | 0.960 |
Why?
|
| Proteome | 3 | 2022 | 42 | 0.950 |
Why?
|
| RNA, Messenger | 3 | 2022 | 311 | 0.930 |
Why?
|
| Cluster Analysis | 2 | 2023 | 47 | 0.720 |
Why?
|
| Nerve Net | 2 | 2019 | 41 | 0.670 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 281 | 0.670 |
Why?
|
| Dementia | 2 | 2022 | 573 | 0.620 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2023 | 388 | 0.560 |
Why?
|
| Genome-Wide Association Study | 6 | 2023 | 284 | 0.520 |
Why?
|
| Models, Neurological | 1 | 2016 | 25 | 0.520 |
Why?
|
| Models, Theoretical | 1 | 2015 | 83 | 0.480 |
Why?
|
| Humans | 41 | 2023 | 28181 | 0.470 |
Why?
|
| Aged, 80 and over | 17 | 2022 | 4848 | 0.470 |
Why?
|
| Aging | 8 | 2023 | 1549 | 0.470 |
Why?
|
| Foot Deformities | 1 | 2014 | 1 | 0.470 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2014 | 1 | 0.470 |
Why?
|
| Pyridoxal Phosphate | 1 | 2014 | 1 | 0.470 |
Why?
|
| DNA Methylation | 5 | 2022 | 165 | 0.460 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 47 | 0.460 |
Why?
|
| Gene Expression | 5 | 2023 | 204 | 0.450 |
Why?
|
| Microglia | 5 | 2023 | 145 | 0.410 |
Why?
|
| Genome, Human | 3 | 2018 | 50 | 0.410 |
Why?
|
| Cognition | 6 | 2021 | 1351 | 0.400 |
Why?
|
| Aged | 19 | 2023 | 9268 | 0.390 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 160 | 0.370 |
Why?
|
| Genotype | 4 | 2019 | 360 | 0.360 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 3 | 2019 | 26 | 0.360 |
Why?
|
| Male | 22 | 2022 | 15232 | 0.340 |
Why?
|
| Hormones | 1 | 2010 | 11 | 0.340 |
Why?
|
| Depressive Disorder, Major | 2 | 2010 | 102 | 0.340 |
Why?
|
| Female | 21 | 2022 | 15692 | 0.330 |
Why?
|
| Amyloid beta-Peptides | 6 | 2021 | 327 | 0.320 |
Why?
|
| Autopsy | 6 | 2019 | 343 | 0.320 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 86 | 0.300 |
Why?
|
| Apolipoprotein E4 | 3 | 2019 | 264 | 0.280 |
Why?
|
| Cohort Studies | 8 | 2020 | 1926 | 0.280 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 57 | 0.270 |
Why?
|
| Motor Activity | 2 | 2019 | 330 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 43 | 0.250 |
Why?
|
| Phenotype | 4 | 2023 | 313 | 0.240 |
Why?
|
| Benchmarking | 1 | 2023 | 32 | 0.210 |
Why?
|
| Apolipoproteins E | 3 | 2020 | 252 | 0.200 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 137 | 0.200 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 24 | 0.200 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2019 | 18 | 0.200 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 85 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 156 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 19 | 0.190 |
Why?
|
| Mutation | 2 | 2014 | 352 | 0.190 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 36 | 0.190 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 7 | 0.190 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2020 | 110 | 0.190 |
Why?
|
| Astrocytes | 2 | 2020 | 150 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 19 | 0.180 |
Why?
|
| Neurons | 4 | 2021 | 343 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2020 | 167 | 0.180 |
Why?
|
| Haplotypes | 2 | 2020 | 60 | 0.180 |
Why?
|
| Models, Genetic | 3 | 2020 | 41 | 0.180 |
Why?
|
| Neurofibrillary Tangles | 2 | 2019 | 193 | 0.180 |
Why?
|
| Peptides | 1 | 2021 | 103 | 0.170 |
Why?
|
| RNA Splicing Factors | 1 | 2020 | 5 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2021 | 90 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2018 | 98 | 0.170 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 39 | 0.170 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 7 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2019 | 15 | 0.170 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 212 | 0.170 |
Why?
|
| Histones | 1 | 2019 | 28 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 7 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 18 | 0.160 |
Why?
|
| Neuroimaging | 1 | 2019 | 128 | 0.150 |
Why?
|
| Seasons | 1 | 2018 | 24 | 0.150 |
Why?
|
| Independent Living | 2 | 2019 | 318 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
| Frontal Lobe | 1 | 2018 | 81 | 0.150 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 113 | 0.150 |
Why?
|
| Brain Infarction | 1 | 2017 | 75 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1142 | 0.140 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 16 | 0.140 |
Why?
|
| Homozygote | 1 | 2017 | 21 | 0.140 |
Why?
|
| Risk Factors | 6 | 2019 | 2388 | 0.140 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 275 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 134 | 0.140 |
Why?
|
| Postural Balance | 1 | 2018 | 123 | 0.130 |
Why?
|
| Lewy Bodies | 4 | 2019 | 194 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 285 | 0.130 |
Why?
|
| Schiff Bases | 1 | 2014 | 1 | 0.120 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 1 | 0.120 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 17 | 0.120 |
Why?
|
| tau Proteins | 3 | 2021 | 235 | 0.120 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 13 | 0.120 |
Why?
|
| Exercise | 1 | 2019 | 469 | 0.120 |
Why?
|
| Mitochondria | 1 | 2014 | 71 | 0.110 |
Why?
|
| Fibromyalgia | 1 | 2014 | 30 | 0.110 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 1223 | 0.110 |
Why?
|
| Gait | 1 | 2018 | 412 | 0.110 |
Why?
|
| Behavior | 1 | 2013 | 25 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 28 | 0.100 |
Why?
|
| Amygdala | 2 | 2010 | 41 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 72 | 0.100 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2013 | 29 | 0.100 |
Why?
|
| Animals | 5 | 2020 | 3750 | 0.100 |
Why?
|
| Mice | 4 | 2020 | 1445 | 0.100 |
Why?
|
| Linear Models | 3 | 2018 | 252 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1385 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2010 | 44 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 67 | 0.080 |
Why?
|
| Alleles | 2 | 2021 | 221 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 369 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 285 | 0.080 |
Why?
|
| Sclerosis | 2 | 2019 | 66 | 0.080 |
Why?
|
| Schizophrenia | 2 | 2018 | 63 | 0.070 |
Why?
|
| Biomarkers | 2 | 2020 | 584 | 0.070 |
Why?
|
| Hippocampus | 2 | 2019 | 278 | 0.070 |
Why?
|
| Species Specificity | 2 | 2020 | 42 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2015 | 43 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 10 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 9 | 0.050 |
Why?
|
| Base Sequence | 1 | 2023 | 108 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 105 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 100 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 108 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 619 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 37 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 5 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 21 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 42 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 23 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 45 | 0.040 |
Why?
|
| Lysosomes | 1 | 2020 | 26 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2020 | 26 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 107 | 0.040 |
Why?
|
| Pharmacology | 1 | 2019 | 1 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 733 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 224 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 14 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 119 | 0.040 |
Why?
|
| Metabolomics | 1 | 2018 | 17 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 21 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 15 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 146 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 16 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 597 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 14 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 78 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 38 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 116 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 102 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 9278 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 125 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 46 | 0.040 |
Why?
|
| Accelerometry | 1 | 2018 | 88 | 0.040 |
Why?
|
| Epigenomics | 1 | 2017 | 19 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 401 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2017 | 58 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 9 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 107 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 93 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 132 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 208 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 216 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 358 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 963 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1808 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 15 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 8091 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 261 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 925 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 54 | 0.030 |
Why?
|
| Amyloid | 1 | 2015 | 56 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 33 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 148 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 475 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 65 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1850 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2018 | 1002 | 0.020 |
Why?
|
| United States | 1 | 2017 | 2148 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 855 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 14 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 59 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 105 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 98 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 437 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2009 | 242 | 0.020 |
Why?
|